Search

everythinglearnresearchcommunity

for

Search:↓

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

A plant-based diet and certain probiotics may improve skin health and reduce inflammation.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Probiotics may help with hair growth and dandruff, but more research is needed.

Blocking certain immune signals can reduce skin damage from radiation therapy.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Higher inflammation markers are linked to more severe alopecia areata.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Hesperidin from orange peels is a promising natural ingredient for skincare due to its multiple beneficial properties.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Blood metabolites significantly influence alopecia areata risk.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Skin diseases like acne and psoriasis are linked to stress, gut health, and inflammation, with new treatments focusing on gut and mind-body approaches.

3D human skin models show promise for dermatology but face challenges in standardization and cost.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

Dihydroartemisinin could be a versatile cosmetic ingredient but needs more research and development.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.

Ixekizumab has known and some unexpected side effects.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.